In an interview with Cinco Dias Rafael Camacho, general director of the Genome Spain Foundation predicts that “biotechnology will be the engine that moves the world in the next century. It explains that the field of biotechnology opens up new business prospects in the sense of serving as a lever and economic boost to the mobilization and transformation of traditional industries such as food, pharmaceutical chemistry and fundamental to the paradigm shift productive.
Moreover, its development to 15 or 20 years, can cost between 2.7% and 3% of GDP of a country like Spain, according to the OECD. Hence, Spain should realize that potential to become a more or less competitive economy.
Bioglane presented his draft on a PCB:
Bioglane-a spin-off of the Higher Council for Scientific Research (CSIC) – has announced its business plan in the Barcelona Science Park (PCB), also presenting results of his pioneering research on a natural substance, fagomina, a iminoazúcar present in the traditional human diet overall almost worldwide.
Creating Bioglane in 2007 from the initiative of researchers from the CSIC and its proposed development of a glucose analogue component, the fagomina, which in 2010 is due to filing for marketing approval in the United States and later in Europe, has established itself as the first company worldwide to have generated sufficient amount of product and demonstrate the nutritional value of their presence in the diet, both to control the harmful effects of refined sugars, such as to improve quality of intestinal flora.
The fagomina delays absorption of glucose found in starches (cereals, potatoes or pasta) and refined sugars, which helps prevent its accumulation in the form of reserves, and also improves the introduction of probiotics, which represents an unprecedented new in the nutritional world.
